LOCUS       NP_000673                450 aa                     PRI 07-JUN-2014
DEFINITION  alpha-2B adrenergic receptor [Homo sapiens].
ACCESSION   NP_000673
VERSION     NP_000673.2  GI:33598960
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 450)
  AUTHORS   De Fusco M, Vago R, Striano P, Di Bonaventura C, Zara F, Mei D, Kim
            MS, Muallem S, Chen Y, Wang Q, Guerrini R and Casari G.
  TITLE     The alpha2B-adrenergic receptor is mutant in cortical myoclonus and
            epilepsy
  JOURNAL   Ann. Neurol. 75 (1), 77-87 (2014)
   PUBMED   24114805
  REMARK    GeneRIF: A mutation in alpha2B-adrenergic receptor is associated
            with autosomal dominant cortical myoclonus and epilepsy.
REFERENCE   2  (residues 1 to 450)
  AUTHORS   Li S, Weerda R, Guenzel F, Wolf OT and Thiel CM.
  TITLE     ADRA2B genotype modulates effects of acute psychosocial stress on
            emotional memory retrieval in healthy young men
  JOURNAL   Neurobiol Learn Mem 103, 11-18 (2013)
   PUBMED   23583499
  REMARK    GeneRIF: Carriers of the ADRA2B functional deletion variant showed
            an impaired recognition and slower retrieval of neutral faces under
            stress.
REFERENCE   3  (residues 1 to 450)
  AUTHORS   Koutroumani M, Daniilidou M, Giannakouros T, Proitsi P, Liapi D,
            Germanou A, Nikolakaki E and Tsolaki M.
  TITLE     The deletion variant of alpha2b-adrenergic receptor is associated
            with decreased risk in Alzheimer's disease and mild cognitive
            impairment
  JOURNAL   J. Neurol. Sci. 328 (1-2), 19-23 (2013)
   PUBMED   23499426
  REMARK    GeneRIF: this study demonstrated for the first time an independent
            contribution of the ADRA2B genetic polymorphism to memory impairment
            and we further suggest a possible protective role of the deletion
            variant against the disease development.
REFERENCE   4  (residues 1 to 450)
  AUTHORS   Wei W, Du C, Lv J, Zhao G, Li Z, Wu Z, Hasko G and Xie X.
  TITLE     Blocking A2B adenosine receptor alleviates pathogenesis of
            experimental autoimmune encephalomyelitis via inhibition of IL-6
            production and Th17 differentiation
  JOURNAL   J. Immunol. 190 (1), 138-146 (2013)
   PUBMED   23225885
  REMARK    GeneRIF: Adenosine alpha2B receptor is upregulated in the peripheral
            blood leukocytes of multiple sclerosis patients.
REFERENCE   5  (residues 1 to 450)
  AUTHORS   Li C, Fan Y, Lan TH, Lambert NA and Wu G.
  TITLE     Rab26 modulates the cell surface transport of alpha2-adrenergic
            receptors from the Golgi
  JOURNAL   J. Biol. Chem. 287 (51), 42784-42794 (2012)
   PUBMED   23105096
  REMARK    GeneRIF: The small GTPase Rab26 regulates the Golgi to cell surface
            traffic of alpha(2)-adrenergic receptors, likely through a physical
            interaction.
REFERENCE   6  (residues 1 to 450)
  AUTHORS   Weinshank RL, Zgombick JM, Macchi M, Adham N, Lichtblau H, Branchek
            TA and Hartig PR.
  TITLE     Cloning, expression, and pharmacological characterization of a human
            alpha 2B-adrenergic receptor
  JOURNAL   Mol. Pharmacol. 38 (5), 681-688 (1990)
   PUBMED   2172775
REFERENCE   7  (residues 1 to 450)
  AUTHORS   Chang AC, Ho TF and Chang NC.
  TITLE     In vitro amplification by polymerase chain reaction of a partial
            gene encoding the third subtype of alpha-2 adrenergic receptor in
            humans
  JOURNAL   Biochem. Biophys. Res. Commun. 172 (2), 817-823 (1990)
   PUBMED   2173582
REFERENCE   8  (residues 1 to 450)
  AUTHORS   McClue SJ and Milligan G.
  TITLE     The alpha 2B adrenergic receptor of undifferentiated neuroblastoma x
            glioma hybrid NG108-15 cells, interacts directly with the guanine
            nucleotide binding protein, Gi2
  JOURNAL   FEBS Lett. 269 (2), 430-434 (1990)
   PUBMED   2169434
REFERENCE   9  (residues 1 to 450)
  AUTHORS   Lomasney JW, Lorenz W, Allen LF, King K, Regan JW, Yang-Feng TL,
            Caron MG and Lefkowitz RJ.
  TITLE     Expansion of the alpha 2-adrenergic receptor family: cloning and
            characterization of a human alpha 2-adrenergic receptor subtype, the
            gene for which is located on chromosome 2
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 87 (13), 5094-5098 (1990)
   PUBMED   2164221
REFERENCE   10  (residues 1 to 450)
  AUTHORS   Regan JW, Kobilka TS, Yang-Feng TL, Caron MG, Lefkowitz RJ and
            Kobilka BK.
  TITLE     Cloning and expression of a human kidney cDNA for an alpha
            2-adrenergic receptor subtype
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 85 (17), 6301-6305 (1988)
   PUBMED   2842764
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from BC133021.1 and AC092603.2.
            This sequence is a reference standard in the RefSeqGene project.
            On Aug 12, 2003 this sequence version replaced gi:4501965.
            Summary: This intronless gene encodes a seven-pass transmembrane
            protein. This protein is a member of a subfamily of G
            protein-coupled receptors that regulate neurotransmitter release
            from sympathetic nerves and from adrenergic neurons in the central
            nervous system. [provided by RefSeq, Apr 2014].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
FEATURES             Location/Qualifiers
     source          1..450
                     /db_xref="taxon:9606"
                     /organism="Homo sapiens"
                     /chromosome="2"
                     /map="2q11.1"
     Protein         1..450
                     /note="alpha-2-adrenergic receptor-like 1; ADRA2B
                     adrenergic, alpha-2B-, receptor; G-protein coupled
                     receptor; alpha-2B adrenoreceptor; alpha-2 adrenergic
                     receptor subtype C2"
                     /product="alpha-2B adrenergic receptor"
                     /calculated_mol_wt="49823"
     Site            13..38
                     /note="propagated from UniProtKB/Swiss-Prot (P18089.3)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          21..>152
                     /note="Serpentine type 7TM GPCR chemoreceptor Srx;
                     pfam10328"
                     /db_xref="CDD:255910"
                     /region_name="7TM_GPCR_Srx"
     Region          35..426
                     /note="7 transmembrane receptor (rhodopsin family);
                     pfam00001"
                     /db_xref="CDD:249497"
                     /region_name="7tm_1"
     Site            49..69
                     /note="propagated from UniProtKB/Swiss-Prot (P18089.3)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            87..107
                     /note="propagated from UniProtKB/Swiss-Prot (P18089.3)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            92
                     /note="Implicated in ligand binding (By similarity);
                     propagated from UniProtKB/Swiss-Prot (P18089.3)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="other"
     Site            129..149
                     /note="propagated from UniProtKB/Swiss-Prot (P18089.3)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            173..193
                     /note="propagated from UniProtKB/Swiss-Prot (P18089.3)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            176
                     /note="Implicated in catechol agonist binding (By
                     similarity); propagated from UniProtKB/Swiss-Prot
                     (P18089.3)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="other"
     Site            180
                     /note="Implicated in catechol agonist binding (By
                     similarity); propagated from UniProtKB/Swiss-Prot
                     (P18089.3)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="other"
     Site            373..396
                     /note="propagated from UniProtKB/Swiss-Prot (P18089.3)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            406..426
                     /note="propagated from UniProtKB/Swiss-Prot (P18089.3)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     CDS             1..450
                     /coded_by="NM_000682.6:97..1449"
                     /gene="ADRA2B"
                     /gene_synonym="ADRA2L1; ADRA2RL1; ADRARL1; alpha-2BAR;
                     ALPHA2BAR"
                     /db_xref="CCDS:CCDS56129.1"
                     /db_xref="GeneID:151"
                     /db_xref="HGNC:HGNC:282"
                     /db_xref="HPRD:00086"
                     /db_xref="MIM:104260"
ORIGIN
        1 mdhqdpysvq ataaiaaait flilftifgn alvilavlts rslrapqnlf lvslaaadil
       61 vatliipfsl anellgywyf rrtwcevyla ldvlfctssi vhlcaisldr ywavsraley
      121 nskrtprrik ciiltvwlia avislppliy kgdqgpqprg rpqcklnqea wyilassigs
      181 ffapclimil vylriyliak rsnrrgprak ggpgqgeskq prpdhggala saklpalasv
      241 asarevnghs kstgekeege tpedtgtral ppswaalpns gqgqkegvcg aspedeaeee
      301 eeeeeeeeec epqavpvspa sacspplqqp qgsrvlatlr gqvllgrgvg aiggqwwrrr
      361 aqltrekrft fvlavvigvf vlcwfpfffs yslgaicpkh ckvphglfqf ffwigycnss
      421 lnpviytifn qdfrrafrri lcrpwtqtaw
//
